59
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Targeting the D1-N-methyl-d-aspartate receptor complex reduces l-dopa-induced dyskinesia in 6-hydroxydopamine-lesioned Parkinson’s rats

, , , , , , , , & show all
Pages 547-555 | Published online: 03 Feb 2016

References

  • ObesoJAOlanouCWNuttJGLevodopa motor complications in Parkinson’s diseaseTrends Neurosci200023Suppl 1S2S711052214
  • BezardEBrotchieJMGrossCEPathophysiology of levodopa-induced dyskinesia: potential for new therapiesNat Rev Neurosci20012857758811484001
  • BhidayasiriRTruongDDMotor complications in Parkinson disease: clinical manifestations and managementJ Neurol Sci20082661–220421517897677
  • HuotPJohnstonTHKoprichJBFoxSHBrotchieJMThe pharmacology of L-DOPA-induced dyskinesia in Parkinson’s diseasePharmacol Rev201365117122223319549
  • OlanowCWObesoJAStocchiFContinuous dopamine-receptor treatment of Parkinson’s disease: scientific rationale and clinical implicationsLancet Neurol20065867768716857573
  • CenciMOhlinKRylanderDPlastic effects of L-DOPA treatment in the basal ganglia and the relevance to the development of dyskinesiaParkinsonism Relat Disord200915Suppl 3S59S6320083009
  • RobeletSMelonCGuilletBSalinPKerkerian-Le GoffLChronic L-DOPA treatment increases extracellular glutamate levels and GLT1 expression in the basal ganglia in a rat model of Parkinson’s diseaseEur J Neurosci20042051255126615341597
  • BrotchieJMNondopaminergic mechanisms in levodopa-induced dyskinesiaMov Dis2005208919931
  • HaraYPickelVMOverlapping intracellular and differential synaptic distributions of dopamine D1 and glutamate N-methyl-D-aspartate receptors in rat nucleus accumbensJ Comp Neurol2005492444245516228995
  • PickelVMColagoEEManiaIMoloshAIRainnieDGDopamine D1 receptors co-distribute with N-methyl-D-aspartic acid type-1 subunits and modulate synaptically-evoked N-methyl-D-aspartic acid currents in rat basolateral amygdalaNeuroscience2006142367169016905271
  • LeeFJXueSPeiLDual regulation of NMDA receptor functions by direct protein-protein interactions with the dopamine D1 receptorCell2002111221923012408866
  • FiorentiniCGardoniFSpanoPDi LucaMMissaleCRegulation of dopamine D1 receptor trafficking and desensitization by oligomerization with glutamate N-methyl-D-aspartate receptorsJ Biol Chem200327822201962020212646556
  • PeiLLeeFJMoszczynskaAVukusicBLiuFRegulation of dopamine D1 receptor function by physical interaction with the NMDA receptorsJ Neurosci20042451149115814762133
  • ScottLKruseMSForssbergHBrismarHGreengardPAperiaASelective up-regulation of dopamine D1 receptors in dendritic spines by NMDA receptor activationProc Natl Acad Sci U S A20029931661166411818555
  • LachowiczJESibleyDRMolecular characteristics of mammalian dopamine receptorsPharmacol Toxicol19978131051139335067
  • MissaleCNashSRRobinsonSWJaberMCaronMGDopamine receptors: from structure to functionPhysiol Rev19987811892259457173
  • DunahAWStandaertDGDopamine D1 receptor-dependent trafficking of striatal NMDA glutamate receptors to the postsynaptic membraneJ Neurosci200121155546555811466426
  • CepedaCLevineMSWhere do you think you are going? The NMDA-D1 receptor trapSci STKE20062006333pe2016670371
  • BozziYBorrelliEDopamine in neurotoxicity and neuroprotection: what do D2 receptors have to do with it?Trends Neurosci200629316717416443286
  • PaxinosGWatsonCThe Rat Brain in Stereotaxic CoordinatesSan DiegoAcademic Press2007
  • PapaSMEngberTMKaskAMChaseTNMotor fluctuations in levodopa treated parkinsonian rats: relation to lesion extent and treatment durationBrain Res19946621–269747859092
  • PuttermanDBMunhallACKozellLBBelknapJKJohnsonSWEvaluation of levodopa dose and magnitude of dopamine depletion as risk factors for levodopa-induced dyskinesia in a rat model of Parkinson’s diseaseJ Pharmacol Exp Ther2007323127728417660384
  • PorrasGBerthetADehayBPSD-95 expression controls L-DOPA dyskinesia through dopamine D1 receptor traffickingJ Clin Invest2012122113977398923041629
  • LindenbachDOstockCYEskow JaunarajsKLBehavioral and cellular modulation of L-DOPA-induced dyskinesia by beta-adrenoceptor blockade in the 6-hydroxydopamine-lesioned ratJ Pharmacol Exp Ther2011337375576521402691
  • MabroukOSMelaFCalcagnoMGluN2A and GluN2B NMDA receptor subunits differentially modulate striatal output pathways and contribute to levodopa-induced abnormal involuntary movements in dyskinetic ratsACS Chem Neurosci20134580881623611155
  • SantiniEValjentEUsielloACritical involvement of cAMP/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesiaJ Neurosci200727266995700517596448
  • SantiniESgambato-FaureVLiQDistinct changes in cAMP and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesiaPLoS One201058e1232220808799
  • BrownAMDeutchAYColbranRJDopamine depletion alters phosphorylation of striatal proteins in a model of ParkinsonismEur J Neurosci200522124725616029214
  • SchwarzeSRHoAVocero-AkbaniADowdySFIn vivo protein transduction: delivery of a biologically active protein into the mouseScience199928554331569157210477521
  • NaiQLiSWangSHUncoupling the D1-N-methyl-D-aspartate (NMDA) receptor complex promotes NMDA-dependent long-term potentiation and working memoryBiol Psychiatry201067324625419846062
  • LadepecheLYangLBouchetDGrocLRegulation of dopamine D1 receptor dynamics within the postsynaptic density of hippocampal glutamate synapsesPLoS One201389e7451224040266
  • ChaseTNOhJDStriatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonismTrends Neurosci200023Suppl 10S86S9111052225
  • PicconiBCentonzeDHakanssonKLoss of bidirectional striatal plasticity in L-DOPA-induced dyskinesiaNat Neurosci20036550150612665799
  • DekundyALundbladMDanyszWCenciMAModulation of L-DOPA-induced abnormal involuntary movements by clinically tested compounds: further validation of the rat dyskinesia modelBehav Brain Res20071791768917306893
  • PascoliVTuriaultMLüscherCReversal of cocaine-evoked synaptic potentiation resets drug-induced adaptive behaviourNature20114817379717522158102
  • CahillEPascoliVTrifilieffPD1R/GluN1 complexes in the striatum integrate dopamine and glutamate signalling to control synaptic plasticity and cocaine-induced responsesMol Psychiatry201419121295130425070539
  • GreengardPThe neurobiology of slow synaptic transmissionScience200129455441024103011691979
  • BateupHSSantiniEShenWDistinct subclasses of medium spiny neurons differentially regulated striatal motor behaviorsProc Natl Acad Sci U S A201010733148451485020682746
  • FiorentiniCRizzettiMCBusiCLoss of synaptic D1 dopamine/N-methyl-D-aspartate glutamate receptor complexes in L-DOPA-induced dyskinesia in the ratMol Pharmacol200669380581216365282
  • AhmedIBoseSKPaveseNGlutamate NMDA receptor dysregulation in Parkinson’s disease with dyskinesiasBrain2011134497998621371994
  • HallettPJDunahAWRavenscroftPAlterations of striatal NMDA receptor subunits associated with the development of dyskinesia in the MPTP-lesioned primate model of Parkinson’s diseaseNeuropharmacology200548450351615755478
  • NishiA1WatanabeYHigashiHTanakaMNairnACGreengardPGlutamate regulation of DARPP-32 phosphorylation in neostriatal neurons involves activation of multiple signaling cascadesProc Natl Acad Sci U S A200510241199120415657149
  • RamseyAJLaaksoACyrMSotnikovaTDSalahpourAMedvedevIOGenetic NMDA receptor deficiency disrupts acute and chronic effects of cocaine but not amphetamineNeuropsychopharmacology200833112701271418185498
  • FanXJinWYWangYTThe NMDA receptor complex: a multifunctional machine at the glutamatergic synapseFront Cell Neurosci2014816024959120
  • ZhangJXuTXHallettPJPSD-95 uncouples dopamine-glutamate interaction in the D1/PSD-95/NMDA receptor complexJ Neurosci20092992948296019261890
  • WangMWongAHLiuFInteractions between NMDA and dopamine receptors: a potential therapeutic targetBrain Res2012147615416322472597